Log in to save to my catalogue

New therapies in the management of Niemann-Pick type C disease: clinical utility of miglustat

New therapies in the management of Niemann-Pick type C disease: clinical utility of miglustat

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_33acba7c06404c4685a8e9d10f38268e

New therapies in the management of Niemann-Pick type C disease: clinical utility of miglustat

About this item

Full title

New therapies in the management of Niemann-Pick type C disease: clinical utility of miglustat

Author / Creator

Publisher

New Zealand: Taylor & Francis Ltd

Journal title

Therapeutics and clinical risk management, 2009, Vol.5 (default), p.877-887

Language

English

Formats

Publication information

Publisher

New Zealand: Taylor & Francis Ltd

More information

Scope and Contents

Contents

Niemann-Pick disease type C (NP-C) is an autosomal recessive disorder characterized by progressive neurological deterioration leading to premature death. The disease is caused by mutations in one of two genes, NPC1 or NPC2, leading to impaired intracellular lipid transport and build-up of lipids in various tissues, particularly the brain. Miglustat...

Alternative Titles

Full title

New therapies in the management of Niemann-Pick type C disease: clinical utility of miglustat

Authors, Artists and Contributors

Author / Creator

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_33acba7c06404c4685a8e9d10f38268e

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_33acba7c06404c4685a8e9d10f38268e

Other Identifiers

ISSN

1178-203X,1176-6336

E-ISSN

1178-203X

DOI

10.2147/TCRM.S5777

How to access this item